L-carnitines effect on the biomarkers of metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials
Biochem Biophys Res Commun 291:13021308 Goldstein BJ, Feinglos MN, Lunceford JK, Johnson J, Williams-Herman DE, Sitagliptin 036 Study Group (2007) Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes
Every battery expert I have talked to agrees on this
doi: 10.1172/JCI32601 57
Common side effects include temporary redness, swelling, mild bruising, or tenderness at injection sites
In such outcome trials of DPP-4 inhibitors, SGLT2 inhibitors, and GLP-1 RAs, the study drug is compared with placebo, with both agents given in addition to standard care